Claim:
As of spring 2026, HIV is now curable.
Rating:
Mostly False
Key Points
- HIV is not curable for the wider population as of this writing, and as a result we’ve rated the claim mostly false.
- A small number of individuals have gone into long-term HIV remission, essentially a functional “cure,” through bone marrow transplants.
- However, bone marrow transplants carry significant risks — including severe infections and death — and are only available to patients with a severe blood or bone marrow disease.
- Scientists do not yet consider long-term HIV remission via bone marrow transplant to be a true “cure” because these operations are still new as of this writing. In other words, it’s too soon to definitively say whether HIV may still be present in the body and rebound at a later stage.
- A modern HIV diagnosis is not a death sentence, and many people with HIV have long and healthy lives. Consistent treatment for people living with HIV can result in an undetectable viral load, meaning they will not transmit HIV to others, but obstacles such as stigma, access to medication and cost of treatment remain.
In April 2026, social media posts widely circulated claims suggesting that HIV had become “curable.”
HIV is curable now. What a good time to be alive.
— Ọládélé 🇳🇬👑 (@Theoladeledada) April 16, 2026
The claim appeared to gain traction following scientific reports about a man from Oslo who entered long-term HIV remission after receiving a bone marrow transplant from a donor with a rare genetic mutation linked to HIV resistance.
While the case represented an important scientific development, experts say it does not mean HIV has become curable for the general population.
What’s True
A small number of patients worldwide have entered long-term HIV remission following specialized bone marrow or stem cell transplants.
These procedures involved donors carrying a rare genetic mutation known as CCR5-delta32, which can make immune cells resistant to HIV.
In some cases, patients stopped HIV medication and the virus did not return, leading researchers to describe these outcomes as a “functional cure” or long-term remission.
What’s False
HIV is not considered broadly curable as of 2026.
The transplant procedures associated with these rare remission cases are extremely risky, medically complex, and intended only for patients already suffering from severe blood cancers or bone marrow diseases.
They are not considered a realistic treatment option for the millions of people living with HIV worldwide.
Scientists also caution that it remains uncertain whether hidden traces of the virus could still remain dormant in the body and potentially return later.
The ‘Oslo patient’ case
The viral claim appears to have originated from a scientific study published in April 2026 involving a 63-year-old man often referred to as the “Oslo patient.”
The patient underwent a stem cell transplant from his brother, who carried two copies of the rare CCR5-delta32 genetic mutation associated with resistance to HIV-1.
After the transplant:
- The patient stopped antiretroviral therapy
- Researchers later found no detectable active HIV in blood or tissue samples
- The virus did not rebound after treatment stopped
Researchers described the outcome as long-term HIV remission.
However, experts still hesitate to call it a definitive cure because HIV can sometimes remain hidden in the body at levels difficult to detect.
Why bone marrow transplants are not a general cure
Bone marrow transplants carry major health risks, including:
- Severe infections
- Organ complications
- Graft-versus-host disease
- Death
According to the published study, procedure-related mortality rates may range between 10% and 20% within the first year.
Because of these dangers, such transplants are only considered for patients who already require them to treat life-threatening cancers or blood disorders.
Experts say it would not be practical or safe to perform these procedures on the more than 30 million people living with HIV globally.
Modern HIV treatment today
Although HIV is not widely curable, modern treatment has dramatically improved outcomes.
People living with HIV who consistently take antiretroviral therapy can often reduce the virus to an “undetectable” level, meaning:
- The virus remains controlled
- They can live long, healthy lives
- They do not sexually transmit HIV to others
However, challenges involving access to medication, healthcare costs, and stigma continue to affect millions worldwide.
What scientists say next
Researchers continue exploring safer approaches toward a future HIV cure, including:
- Gene-editing technologies
- Engineered antibodies
- Immune-based therapies
Some scientists believe broader functional cures could eventually become possible, but experts caution that the world is not there yet.
The Bottom Line
Claims that HIV is “now curable” overstate current scientific reality.
A small number of patients have entered long-term HIV remission through rare and high-risk medical procedures, but HIV is not considered curable for the general population as of 2026.
Clarifact therefore rates the claim as Mostly False.
Sources:
- Arslan, Shukaib, et al. “Risks and Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies in Patients with HIV Infection.” Biology of Blood and Marrow Transplantation, vol. 25, no. 8, Aug. 2019, pp. e260–67, https://doi.org/10.1016/j.bbmt.2019.03.021.
- Bader, Peter, et al. “Documentation of Engraftment and Chimerism after HCT.” The EBMT Handbook, Springer International Publishing, 2024, pp. 183–88, https://doi.org/10.1007/978-3-031-44080-9_21.
- Bouabida, Khayreddine, et al. “Challenges and Barriers to HIV Care Engagement and Care Cascade: Viewpoint.” Frontiers in Reproductive Health, vol. 5, no. 5, Frontiers Media, July 2023, https://doi.org/10.3389/frph.2023.1201087.
- Cleveland Clinic. “Graft versus Host Disease (GvHD) | Cleveland Clinic.” Cleveland Clinic, 2023, my.clevelandclinic.org/health/diseases/10255-graft-vs-host-disease-an-overview-in-bone-marrow-transplant.
- —. “What Is Antiretroviral Therapy?” Cleveland Clinic, 18 Sept. 2023, my.clevelandclinic.org/health/treatments/antiretroviral-therapy.
- Dapcevich, Madison. “Snopes Tips: Why Care If Research Is ‘Peer-Reviewed’?” Snopes, Snopes.com, 30 Mar. 2022, www.snopes.com/news/2022/03/30/snopes-tips-why-care-if-research-is-peer-reviewed/. Accessed 1 May 2026.
- “Despite Gains in Bone Marrow Transplant Survival, Late Mortality Still a Concern, Study Finds.” Uab.edu, 2022, www.uab.edu/reporter/research-innovation/despite-gains-in-bone-marrow-transplant-survival-late-mortality-still-a-concern-study-finds.
- Gometz, Emma. “Person Functionally Cured of HIV after Bone Marrow Transplant from Sibling.” Scientific American, 13 Apr. 2026, www.scientificamerican.com/article/person-functionally-cured-of-hiv-after-bone-marrow-transplant-from-sibling/.
- Herschander, Sara. “Why America’s HIV Epidemic Hasn’t Ended.” Vox, 24 Apr. 2026, www.vox.com/future-perfect/486596/prep-hiv-epidemic-america.
- Lanese, Nicoletta. “‘Oslo Patient’ Likely Cured of HIV after Getting Stem Cell Transplant from His Brother, Who Is Genetically Resistant to the Virus.” Live Science, 13 Apr. 2026, www.livescience.com/health/hiv/oslo-patient-likely-cured-of-hiv-after-getting-stem-cell-transplant-from-his-brother-who-is-genetically-resistant-to-the-virus. Accessed 1 May 2026.
- Myhre, Anders Eivind, et al. “Long-Term HIV-1 Remission Achieved through Allogeneic Haematopoietic Stem Cell Transplant from a CCR5Δ32/Δ32 Sibling Donor.” Nature Microbiology, Springer Science and Business Media LLC, Apr. 2026, https://doi.org/10.1038/s41564-026-02304-8.
- Teagle, Andrea, and Knowable Magazine. “A ‘Functional Cure’ for HIV May Be in Reach, Early Trials Suggest.” Live Science, Dec. 2025, www.livescience.com/health/hiv/a-functional-cure-for-hiv-may-be-in-reach-early-trials-suggest.
- UNAIDS. “Global HIV & AIDS Statistics — 2024 Fact Sheet.” UNAIDS, 2025, www.unaids.org/en/resources/fact-sheet.
